Firms like Indian Immunologicals (IIL) and Wockhardt are in talks for manufacturing tie-ups with US vaccine major Moderna for its mRNA platform-based vaccine, sources said. “There are two specific steps in vaccine manufacturing. One is making the drug substance, and another is filling the drug substance in vials.

If a foreign player supplies the drug substance, then several Indian players have fill-finish capabilities to make the final product. This would typically enhance the vaccine maker’s capacity and reach in this market,” said a person close to the development. …


Similar articles:

  1. Oxford preparing COVID-19 vaccine versions to fight virus variants: Report []

Leave a Reply

Your email address will not be published. Required fields are marked *